Development and initial cohort validation of the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) for use across musculoskeletal care pathways.
Jonathan C HillSujin KangElena BenedettoHelen MyersSteven BlackburnStephanie SmithKate M DunnElaine HayJonathan ReesDavid BeardSion Glyn-JonesKaren BarkerBenjamin EllisRay FitzpatrickAndrew PricePublished in: BMJ open (2016)
A new musculoskeletal outcome measure has been developed through a coproduction process with patients to capture prioritised outcomes for use throughout the pathway and with different musculoskeletal conditions. Four validation cohorts found that the MSK-HQ had high completion rates, excellent test-retest reliability and strong convergent validity with reference standards. Further validation studies are ongoing, including a cohort with rheumatoid/inflammatory arthritis.
Keyphrases
- healthcare
- rheumatoid arthritis
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- public health
- palliative care
- mental health
- cross sectional
- prognostic factors
- rheumatoid arthritis patients
- quality improvement
- skeletal muscle
- risk assessment
- metabolic syndrome
- chronic pain
- climate change
- patient reported outcomes
- glycemic control